Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3Other hematologic neoplasm 3Myeloid 3Lymphoid 3Sarcoma 2Other neoplasm 2Dermatologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Anemia, Refractory, with Excess of Blasts 24Myelodysplastic Syndromes 23Leukemia, Lymphocytic, Chronic, B-Cell 21Leukemia, Myelomonocytic, Chronic 20Hodgkin Disease 19Myeloproliferative Disorders 18Multiple Myeloma 16Lymphoma, Non-Hodgkin 16Leukemia 15Primary Myelofibrosis 14Lymphoma 14Congenital Abnormalities 14Anemia, Aplastic 14Lymphoma, Follicular 13Leukemia, Myeloid, Chronic-Phase 13Leukemia, Myeloid, Accelerated Phase 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Burkitt Lymphoma 11Lymphoma, B-Cell, Marginal Zone 10Neoplasms, Plasma Cell 9Myelodysplastic-Myeloproliferative Diseases 9Lymphoma, Mantle-Cell 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9Graft vs Host Disease 9Polycythemia Vera 8Blast Crisis 8

Interventions

Epoetin Alfa 3Darbepoetin alfa 3fludarabine phosphate 2Therapeutics 2Peripheral Blood Stem Cell Transplantation 2Cyclophosphamide 2ferrous sulfate 1ferric gluconate 1Valganciclovir 1Tetradecanoylphorbol Acetate 1Tacrolimus 1Sucrose 1Radiotherapy 1Polymerase Chain Reaction 1Mycophenolic Acid 1Ganciclovir 1Foscarnet 1Fluorescent Antibody Technique 1Flow Cytometry 1Filgrastim 1Drug Therapy 1Dapsone 1Antiviral Agents 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Immunoglobulin Light-chain Amyloidosis × Tacrolimus × Classical hematology × Clear all
NCT00255710 2010-03-17

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
60 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡